meglumine has been researched along with MS (Multiple Sclerosis) in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.00) | 18.7374 |
1990's | 8 (40.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Codjia, P; Cotton, F; Durand-Dubief, F; Hannoun, S; Kocevar, G; Maucort-Boulch, D; Sappey-Marinier, D; Vukusic, S | 1 |
Barile, A; Di Cesare, E; Marsecano, C; Michelini, G; Perri, M; Splendiani, A; Vellucci, V | 1 |
Docagne, F; Fournier, AP; Gauberti, M; Macrez, R; Quenault, A; Vivien, D | 1 |
Darmon-Kern, E; Desché, P; Lancelot, E; Laurent, AC; Raynaud, JS | 1 |
Splendiani, A | 1 |
Baalbaki, M; El Ayoubi, NK; Haddad, R; Hannoun, S; Hourani, R; Issa, R; Khoury, SJ; Yamout, BI | 1 |
Brochet, B; Crombé, A; de Roquefeuil, E; Dousset, V; Durieux, M; Ouallet, JC; Ruet, A; Saranathan, M; Tourdias, T | 1 |
Doerfler, A; Hosten, N; Jansen, O; Langner, S; Saake, M; Schwenke, C; Weibart, M | 1 |
Brochet, B; Dousset, V; Filippi, M; Kanagaki, M; Miller, DH; Petry, KG; Pruvo, JP; Radüe, EW; Roggerone, S; Rovaris, M; Tourdias, T | 1 |
Tartaro, A | 1 |
Ahn, SS; Guttmann, CR; Hsu, L; Jolesz, FA; Kikinis, R | 1 |
Barkhol, F; Hommes, OR; Polman, CH; Tas, MW; Valk, J; van Walderveen, MA | 1 |
Baratti, C; Campi, A; Comi, G; Filippi, M; Martinelli, V; Rovaris, M; Scotti, G | 1 |
Bydder, GM; De Coene, B; Hajnal, JV; Pennock, JM | 1 |
Bash, C; Frank, JA; Maloni, H; McFarland, H; Petrella, J; Stone, L | 1 |
Avolio, C; Calò, A; De Robertis, F; Defazio, G; Livrea, P; Manzari, C; Simone, IL; Trojano, M | 1 |
Bash, CN; Calabresi, PA; Dambrosia, JM; Frank, JA; Maloni, H; McFarland, HF; Stone, LA; Tranquill, LR | 1 |
Algra, PR; Barkhof, F; Heijboer, RJ | 1 |
Braffman, BH; Brorson, JR; Goldberg, HI; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
5 trial(s) available for meglumine and MS (Multiple Sclerosis)
Article | Year |
---|---|
MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3T.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Reproducibility of Results; Young Adult | 2015 |
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Topics: Adult; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Multiple Sclerosis; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Topics: Adult; Chi-Square Distribution; Contrast Media; Dextrans; Disability Evaluation; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Phenotype; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
MultiHance in multiple sclerosis: update of a study in progress.
Topics: Adolescent; Adult; Brain; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Plaque, Amyloid | 2004 |
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Topics: Adult; Biomarkers; Brain; Cell Adhesion Molecules, Neuronal; Cerebrospinal Fluid; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 1997 |
15 other study(ies) available for meglumine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Topics: Cerebellar Nuclei; Contrast Media; Gadolinium DTPA; Gray Matter; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2022 |
Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2018 |
Reduced spinal cord parenchymal cerebrospinal fluid circulation in experimental autoimmune encephalomyelitis.
Topics: Animals; Brain; Cerebrospinal Fluid; Cisterna Magna; Contrast Media; Encephalomyelitis, Autoimmune, Experimental; Female; Indocyanine Green; Magnetic Resonance Imaging; Meglumine; Mice; Multiple Sclerosis; Organometallic Compounds; Parenchymal Tissue; Spinal Cord | 2019 |
Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) pati
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2018 |
Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Cerebellar Nuclei; Child; Cohort Studies; Contrast Media; Female; Globus Pallidus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies; Young Adult | 2019 |
The evolution of multiple sclerosis lesions on serial MR.
Topics: Adult; Brain; Contrast Media; Drug Combinations; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1995 |
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Sensitivity and Specificity | 1995 |
Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
Topics: Acute Disease; Adolescent; Adult; Aged; Brain; Contrast Media; Diagnosis, Differential; Drug Combinations; Encephalomyelitis; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Myelitis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
MRI of the brain stem using fluid attenuated inversion recivery pulse sequences.
Topics: Adult; Brain Diseases; Brain Neoplasms; Brain Stem; Cerebral Infarction; Cerebrospinal Fluid Shunts; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Hydrocephalus; Lung Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Sarcoidosis | 1993 |
Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.
Topics: Adjuvants, Immunologic; Adult; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Nerve Fibers, Myelinated; Organometallic Compounds; Pentetic Acid | 1996 |
Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Topics: Adolescent; Adult; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium DTPA; Humans; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1996 |
Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
Topics: Adult; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy | 1992 |
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Blood-Brain Barrier; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Time Factors | 1988 |
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed | 1987 |